Ribosomal protein L17 pseudogene 31 (RPL17P31)

RPL17P31 (ribosomal protein L17 pseudogene 31) is annotated as a processed pseudogene in the human genome[4][7]. Pseudogenes are genomic DNA sequences similar to known genes—here, similar to the functional ribosomal protein L17 (RPL17)[8][11]—but have typically lost the ability to code for a protein due to mutations or sequence changes. RPL17P31 is not expressed as a functional protein and does not participate in the essential biological processes attributed to ribosomal proteins, such as protein synthesis. It is not recognized as a therapeutic target, biomarker, or disease-associated locus. There is no evidence of drug interactions, disease involvement, or any safety or therapeutic challenges related to this entity.

Other names

RPL17_21_910RPL17P31